Janet Graesser

VP, Corporate Communications & Investor Relations at Vaxcyte

Janet brings over 20 years of healthcare communications experience across a variety of areas, including corporate communications and strategy, public relations and organizational communications. Prior to joining Vaxcyte, she established her own consulting practice that successfully supported integrated communications for both large and small biotech companies. Previously, she held an operating role at Johnson & Johnson (J&J) with responsibility for global internal and external communications across seven J&J medical device companies, including Cordis. Janet remained with Cordis following its acquisition by Cardinal Health, serving as the Vice President of Global Communications and Strategy Implementation. Janet also dedicated 13 years of her career working at leading healthcare communications firms, ultimately serving as an Executive Vice President, delivering communications strategy and implementation to biotech, pharmaceutical and consumer health companies, including Amgen, GSK, J&J, Pfizer and Merck.

In her early career, Janet followed her interest in public policy and government by working at the California State Capitol, on Capitol Hill in Washington D.C. and on political campaigns. Janet earned her BA in communications, with an emphasis in print journalism, and a minor in political science from Santa Clara University.

Links

Previous companies

Johnson & Johnson logo

Org chart

Timeline

  • VP, Corporate Communications & Investor Relations

    Current role

View in org chart